Varex Imaging Corporation (VREX)
| Market Cap | 781.42M +64.0% |
| Revenue (ttm) | 865.00M +5.3% |
| Net Income | 22.10M |
| EPS | 0.52 |
| Shares Out | 42.15M |
| PE Ratio | 35.66 |
| Forward PE | 20.37 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,186,147 |
| Open | 18.50 |
| Previous Close | 18.47 |
| Day's Range | 18.48 - 18.54 |
| 52-Week Range | 9.09 - 18.63 |
| Beta | 0.96 |
| Analysts | Hold |
| Price Target | 18.90 (+1.94%) |
| Earnings Date | Aug 10, 2026 |
About VREX
Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. It operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers. This segment's products... [Read more]
Financial Performance
In fiscal year 2025, Varex Imaging's revenue was $844.60 million, an increase of 4.14% compared to the previous year's $811.00 million. Losses were -$70.30 million, 44.1% more than in 2024.
Financial StatementsAnalyst Summary
According to 3 analysts, the average rating for VREX stock is "Hold." The 12-month stock price target is $18.9, which is an increase of 1.94% from the latest price.
News
Varex Imaging Proxy statement: Proxy filing
Varex Imaging filed a proxy statement on September 8, 2026, providing details for shareholder voting and corporate governance matters.
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Varex Imaging Corporation (Nasdaq – VREX), Synlogic, Inc. (OTC – SYBX), Bowman Consulting Group Ltd. (Nasdaq – BWMN), Nathan's Famous, Inc. (Nasdaq – NATH)
BALA CYNWYD, Pa., Aug. 28, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (j...
Varex Imaging downgraded to Market Perform from Outperform at CJS Securities
CJS Securities downgraded Varex Imaging (VREX) to Market Perform from Outperform with an $18.90 price target
Varex Imaging Proxy statement: Proxy filing
Varex Imaging filed a proxy statement on August 12, 2026, providing details for shareholder voting and corporate governance matters.
Varex Imaging downgraded to Perform from Outperform at Oppenheimer
Oppenheimer downgraded Varex Imaging (VREX) to Perform from Outperform without a price target after the company agreed to be acquired by Teledyne Technologies (TDY) for $18.90 per share in cash.
Varex Imaging Earnings release: Q3 2026
Varex Imaging released its Q3 2026 earnings on August 10, 2026, summarizing the period's financial results.
Varex Imaging Quarterly report: Q3 2026
Varex Imaging has published its Q3 2026 quarterly earnings report on August 10, 2026.
Varex Imaging downgraded to Neutral from Buy at B. Riley
B. Riley downgraded Varex Imaging (VREX) to Neutral from Buy with a price target of $18.90, up from $18, after the company agreed to be acquired by Teledyne Technologies (TDY)…
Varex Imaging downgraded to Neutral from Buy at Sidoti
Sidoti analyst James Sidoti downgraded Varex Imaging (VREX) to Neutral from Buy with a $19 price target after Teledyne (TDY) agreed to acquire all of the outstanding common shares of…
Varex Imaging Proxy statement: Proxy filing
Varex Imaging filed a proxy statement on August 10, 2026, providing details for shareholder voting and corporate governance matters.
Varex Imaging Proxy statement: Proxy filing
Varex Imaging filed a proxy statement on August 10, 2026, providing details for shareholder voting and corporate governance matters.
Varex Imaging Proxy statement: Proxy filing
Varex Imaging filed a proxy statement on August 10, 2026, providing details for shareholder voting and corporate governance matters.
Varex Imaging Proxy statement: Proxy filing
Varex Imaging filed a proxy statement on August 10, 2026, providing details for shareholder voting and corporate governance matters.
Teledyne Technologies to Buy Varex Imaging for $1.1 Billion
Teledyne Technologies said it will buy Varex Imaging for about $1.1 billion, inclusive of equity awards and debt.
Varex Imaging cancels Q3 earnings conference call
In light of the announced transaction with Teledyne (TDY) Technologies Incorporated, and as is customary during the pendency of such a transaction, Varex has cancelled its earnings conference call for...
Teledyne to acquire Varex Imaging in $1.1 billion deal
Sensing-systems maker Teledyne Technologies agreed to acquire Varex Imaging in an all-cash transaction valued at approximately $1.1 billion, paying $18.90 per share for the medical imaging ...
Varex Imaging reports Q3 non-GAAP EPS 31c, consensus 20c
Reports revenue $211M, consensus $215.5M. “Third-quarter product sales before the IEEPA-related customer reimbursement adjustment were approximately $217 million, reflecting strong growth in Industria...
Varex Announces Financial Results for Third Quarter Fiscal Year 2026
SALT LAKE CITY--(BUSINESS WIRE)--Varex Q3 FY26 Earnings.
Teledyne to acquire Varex Imaging for $18.90 per share in cash, or $1.1B
06:56 EDT Teledyne (TDY) to acquire Varex Imaging (VREX) for $18.90 per share in cash, or $1.1B
Teledyne to acquire Varex Imaging for $18.90 per share in cash, or $1.1B
Teledyne Technologies (TDY) and Varex Imaging (VREX) jointly announced that they have entered into a definitive agreement under which Teledyne will acquire all of the outstanding common shares of Vare...
Teledyne to Acquire Varex Imaging Corporation
THOUSAND OAKS, Calif. & SALT LAKE CITY--(BUSINESS WIRE)--Teledyne Technologies Incorporated (NYSE:TDY) (“Teledyne”) and Varex Imaging Corporation (NASDAQ:VREX) (“Varex”) jointly announced today that t...
Varex Schedules Third Quarter Fiscal Year 2026 Earnings Release and Conference Call
SALT LAKE CITY--(BUSINESS WIRE)--VAREX SCHEDULES THIRD QUARTER FISCAL YEAR 2026 EARNINGS RELEASE AND CONFERENCE CALL.
Varex Imaging Transcript: Jefferies Global Healthcare Conference 2026
Management highlighted stable growth, new annual guidance, and three major growth drivers: India expansion, cargo inspection, and photon counting. AI and digital infrastructure are key enablers, while recent debt refinancing supports strategic flexibility.
Varex to Present at the Jefferies Global Healthcare Conference
SALT LAKE CITY--(BUSINESS WIRE)--Varex Imaging Corporation (Nasdaq: VREX) announced today that management is scheduled to present at the Jefferies Global Healthcare Conference in New York. Management ...
Varex Imaging reports Q2 adjusted EPS 21c, consensus 21c
Reports Q2 revenue $216M, consensus $216.92M. “Demand remained solid in the second quarter, with continued momentum across both our Medical and Industrial businesses driven by global CT, cargo systems...